Morepen Laboratories

Market Cap

3,400.10 Cr

EPS

1.88

PE Ratio

27.22

Dividend Yield

0.00 %

Industry

Healthcare

52 Week High

100.90

52 Week Low

42.00

PB Ratio

3.09

Debt to Equity

0.03

Sector

Pharmaceuticals

Company News

View All News

Morepen Laboratories: CDSCO Approves Studies for Fatty Liver Drug Resmetirom16 hours ago

Morepen Laboratories received CDSCO approval to conduct bioequivalence studies for Resmetirom, a drug treating non-alcoholic steatohepatitis (NASH). The company plans to start clinical trials and is considering out-licensing opportunities. The global NASH treatment market is expected to grow from $2.5 billion in 2024 to over $16 billion by 2032.

Morepen Laboratories: Receives Approval for Resmetirom Bioequivalence Studies20 hours ago

Morepen Laboratories has obtained CDSCO approval to conduct bioequivalence studies for Resmetirom tablets, a potential NASH treatment, in 60mg, 80mg, and 100mg dosages. This positions Morepen among the first Indian pharma companies ready for the drug's global launch. The global NASH treatment market is projected to grow from $2.5 billion in 2024 to over $16 billion by 2032.

Morepen Labs to Launch New Fatty Liver Drug Resmetirom21 hours ago

Morepen Laboratories has announced plans to introduce Resmetirom, a novel medication for the treatment of fatty liver disease. This move represents a significant expansion of the company's pharmaceutical portfolio and could potentially address a growing health concern.

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,805.50	#1 4,41,861.50	36.71	#1 49,887.20	12.06	#1 9,648	13.77	59.04
Divis Laboratories	6,108.00	1,59,984.60	78.50	8,184.00	0.89	1,600	#1 64.53	60.56
Cipla	1,541.50	1,25,592.20	24.94	26,520.70	14.17	4,155	47.38	58.71
Torrent Pharmaceuticals	3,322.70	1,12,871.60	60.37	10,785.70	11.59	1,656	13.54	58.74
Mankind Pharma	2,556.90	1,05,636.60	51.68	10,615.60	19.57	1,942	-16.38	59.78
Dr Reddys Laboratories	1,176.00	1,00,026.20	#1 18.27	28,905.40	12.36	5,578	1.69	53.18
Lupin	2,067.10	96,120.10	32.90	20,141.50	#1 19.94	1,936	38.82	53.30
Zydus Life Science	888.05	89,207.70	19.71	19,831.50	13.82	3,831	29.92	52.81
Aurobindo Pharma	1,209.60	72,437.60	19.93	29,559.20	17.55	3,169	-10.04	55.67
Abbott	30,100.00	63,280.40	47.92	6,097.20	10.80	1,201	16.01	50.02

Growth Rate

Revenue Growth

19.72 %

Net Income Growth

149.61 %

Cash Flow Change

180.48 %

ROE

121.79 %

ROCE

113.54 %

EBITDA Margin (Avg.)

68.27 %

Quarterly Financial Results

Quarterly Financials	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Revenue	132	151	156	172	164	174	215	220	203	216	235	208	259	340	310	291	388	398	399	372	303	404	350	367	404	425	449	427	459	443	458
Expenses	121	130	137	154	152	157	195	197	184	198	215	188	231	305	278	256	343	353	364	350	288	374	328	348	375	388	394	375	404	394	417
EBITDA	11	20	19	18	12	17	19	23	20	18	20	21	28	36	33	35	45	45	35	22	16	30	22	19	29	37	55	53	55	49	41
Operating Profit %	7 %	13 %	12 %	10 %	7 %	10 %	8 %	10 %	10 %	7 %	7 %	9 %	10 %	9 %	10 %	11 %	11 %	11 %	8 %	5 %	5 %	7 %	6 %	4 %	7 %	8 %	11 %	11 %	11 %	10 %	8 %
Depreciation	9	8	8	10	9	10	10	11	12	8	9	9	8	8	8	7	7	7	7	7	7	7	7	7	8	8	8	10	6	2	4
Interest	1	1	1	1	0	0	0	1	0	0	1	1	0	0	1	-0	0	-9	1	1	0	1	1	1	0	1	2	1	1	1	1
Profit Before Tax	1	11	10	7	3	7	9	11	8	9	11	11	20	28	24	28	39	47	27	14	8	22	14	11	21	29	44	42	48	46	35
Tax	0	0	0	0	0	-0	0	0	0	5	0	0	0	0	0	1	8	10	6	2	3	7	5	3	6	7	12	14	12	11	9
Net Profit	1	11	10	7	3	7	9	11	8	4	11	11	19	27	24	27	31	37	22	12	6	16	9	8	15	21	32	29	36	35	27
EPS in ₹	0.03	0.25	0.23	0.15	0.05	0.16	0.20	0.23	0.17	0.09	0.24	0.25	0.43	0.60	0.53	0.59	0.68	0.83	0.48	0.27	0.12	0.33	0.15	0.16	0.29	0.42	0.63	0.54	0.71	0.65	0.49

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	489	524	538	586	615	664	858	1,070	1,111	1,293
Fixed Assets	323	297	272	264	236	216	225	252	267	307
Current Assets	115	157	192	243	300	372	527	734	756	889
Capital Work in Progress	0	0	0	0	0	0	2	14	17	25
Investments	0	0	0	0	0	1	1	0	0	1
Other Assets	167	227	267	321	379	446	631	804	827	960
Total Liabilities	489	524	538	586	615	664	858	1,070	1,111	1,293
Current Liabilities	128	167	325	340	339	351	404	457	321	402
Non Current Liabilities	74	58	18	20	23	28	30	36	37	44
Total Equity	287	300	196	226	253	284	424	578	752	847
Reserve & Surplus	78	91	106	136	163	194	291	457	651	745
Share Capital	210	210	90	90	90	90	90	96	102	102

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-0	-5	3	-1	4	4	28	-26	6	-5
Investing Activities	-32	-27	-14	-27	-13	-13	-70	-32	-47	-83
Operating Activities	51	50	41	63	17	11	51	-60	-91	73
Financing Activities	-19	-27	-24	-38	-0	6	47	66	144	5

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	May 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Aug 2024	Sept 2024	Dec 2024	Mar 2025
Promoter	34.54 %	34.54 %	34.54 %	34.54 %	38.38 %	36.74 %	36.74 %	38.22 %	38.22 %	38.22 %	38.22 %	38.22 %	38.22 %	38.22 %	38.22 %	35.65 %	35.65 %	35.65 %	35.65 %
FIIs	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	1.29 %	0.00 %	1.85 %	1.67 %	7.72 %	2.08 %	2.22 %	1.94 %
DIIs	2.89 %	2.03 %	1.26 %	1.16 %	1.07 %	4.07 %	4.07 %	3.60 %	3.74 %	2.93 %	2.33 %	2.28 %	2.00 %	2.15 %	2.15 %	2.90 %	1.70 %	1.64 %	1.67 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %
Public / Retail	42.97 %	43.89 %	44.82 %	45.18 %	42.50 %	40.88 %	40.91 %	43.63 %	44.03 %	45.04 %	45.49 %	45.56 %	44.44 %	45.03 %	45.22 %	41.89 %	48.16 %	48.35 %	48.76 %
Others	19.60 %	19.54 %	19.38 %	19.12 %	18.05 %	18.31 %	18.29 %	14.53 %	13.99 %	13.80 %	13.95 %	12.64 %	15.33 %	12.74 %	12.74 %	11.83 %	12.41 %	12.12 %	11.96 %
No of Share Holders	1,65,609	2,30,611	2,44,924	2,55,155	2,60,933	2,83,547	2,87,115	2,87,370	3,06,030	3,06,150	3,01,832	3,04,001	3,04,289	3,36,019	3,48,766	3,52,839	4,30,929	4,48,361	4,68,860